Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-02-22

Clinical Trial Update: The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome [NA]

View source ↗

Summary

This clinical trial update indicates that the study on the effect of human albumin infusion on VEGF levels in women at risk for ovarian hyperstimulation syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Albumin Infusion (Human serum albumin)

Snippet

Sponsor: Yale University | Conditions: Ovarian Hyperstimulation Syndrome | NA | Status: WITHDRAWN